A new article, coauthored by HICCC member Nathalie Moise, MD makes the case for doing more to promote anti-racist mental health care and to take steps for racial equity in clinics and communities.
New clinical trial studies the application of focused ultrasound technique to deliver chemotherapy in patients with DIPG, an aggressive type of brain cancer.
Twelve research teams led by Columbia faculty, across diverse disciplines, have been awarded a Columbia Life Science Accelerator pilot grant for their inventive lab-to-market projects.
“I hope that our study raises awareness that even a brief exposure to these addictive medications for surgery-related pain or anxiety can lead to long-term use,” says first author Dr. Jacob C. Cogan.
In our Disruptors column, Gordana Vunjak-Novakovic discusses groundbreaking work between engineers and cancer researchers to accelerate personalized therapeutics and better understand the disease.
Dr. Dawn Hershman recognized with 2021 Mentor of the Year Award, an annual award bestowed by Columbia University Irving Medical Center and the Irving Institute for Clinical and Translational Research.
